| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b1147c26f61e06e9aafa45d211cf098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1d7ed4bea5d30ece8e929a8ddbd5fda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c9b338290117644c327cfe155ec035b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 |
| filingDate |
2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae9a0889737ac71e7a758bf930475442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47cd87e7e4ea2396f0a95e92b72cb35d |
| publicationDate |
2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007041327-A1 |
| titleOfInvention |
Compositions comprising hypsizygus ulmarius extract |
| abstract |
Disclosed are topical compositions comprising extracts of Hypsizygus ulmarius in amounts that are effective to influence LTB4-mediated chemotaxis and/or IL-1β mediated adhesion of polymorphonuclear leukocytes. The hypsizygus ulmarius extract may be used alone or in combination with secondary anti-inflammatory and skin active agents, such as other mushroom and/or natural extracts. The secondary anti-inflammatory agents may or may not function by antagonizing LTB4-mediated chemotaxis and IL-1β mediated adhesion. The extract may be incorporated into a cosmetically acceptable vehicle. The present invention includes methods of treating skin inflammation by applying to inflamed skin, anti-inflammatory effective amounts of Hypsizygus ulmarius extract in a defined treatment regimen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012514634-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8545851-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107519468-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2544655-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2544655-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009043671-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9687517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782448-B2 |
| priorityDate |
2005-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |